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1. Introduction
Fever is a normal physiological response to illness 
that facilitates and accelerates recovery. Although 
there is no evidence that children with fever are at 
increased risk for adverse outcomes, fever in children 
is one of the most common reasons for parents or caregivers to 
seek medical attention for their child. It is frequently a cause for 
concern among parents and healthcare providers who fear that it 
may be associated with increased morbidity, such as seizures, brain 
damage or death.[1,2] Furthermore, there is confusion about how and 
whether to manage fever. Antipyretics are frequently prescribed or 
purchased over-the-counter (OTC), specifically to bring down body 
temperature in an ill child,[2-5] paracetamol and ibuprofen being the 
most frequently purchased OTC medicines for children.[3]
Although fevers are often a presenting symptom of a self-limiting 
viral infection, they are also associated with serious bacterial infections, 
such as meningitis and pneumonia, and other non-infective illnesses. 
Therefore, the underlying illness causing the fever needs to be 
determined and it is essential to be able to distinguish between a child 
with fever who is at high risk of serious illness and a child who requires 
specific treatment, hospitalisation or specialist care, and those at low 
risk who can be managed conservatively at home. This is not only true 
for clinicians, but also for pharmacists and pharmacy workers, who 
may be the first to see the ill child or caregiver. 
This guideline has been developed to assist pharmacists, primary 
healthcare workers and general practitioners in risk-stratifying children 
who present with fever, deciding on when to refer, the appropriate use 
of antipyretic medication and how to advise parents and caregivers. 
2. Methods
A PubMed search was performed to identify recent international 
guidelines and publications on the management of childhood fever. 
After review, a multidisciplinary group of clinicians who treat 
children attended a discussion forum to develop recommendations 
that are concise and simple to follow, based on the available evidence 
and their own clinical experience. Standard levels of evidence were 
assigned to support the recommendations as follows: (A) at least 
two randomised trials; (B) single randomised clinical trial or large 
non-randomised studies; and (C) consensus opinion of the experts 
based on observational studies and clinical experience. Therefore, 
the guidelines offered here do not constitute inflexible treatment 
recommendations. 
3.  Definition of fever and general 
principles
• Fever is defined as a body temperature ≥38oC. (Evidence B)
• Fever in itself is not detrimental, but rather a normal physiological 
response to infection or illness. In the absence of a diagnosis, 
treatment with the sole aim of reducing temperature is inappropriate 
and some febrile children will recover more quickly if the fever is 
not treated.[1,2] (Evidence B)
• Most fevers are due to a self-limiting viral infection, but bacterial 
infections and other causes must be excluded.[1]
• Serious bacterial infection is more common in young children.
• Any fever in a child aged <3 months is significant and should be 
thoroughly investigated and referred to specialist care if the source 
of the fever cannot be found.
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4. Measurement of body temperature
• Body temperature should be measured in the ear using an infrared 
tympanic thermometer, or in the axilla. (Evidence B)
• Oral and rectal routes should not be used to measure body 
temperature in a child.
• Re-usable thermometers should be washed between use. 
4.1 Axillary measurement
• Do not measure temperature directly after bathing.
• Ensure that the child’s axilla is dry. 
• If using a glass thermometer, before placing it in the axilla, 
shake the thermometer until the liquid is below the 36oC line. 
(Evidence C)
• Place the tip of the thermometer in the armpit and lightly press the 
child’s elbow against the chest to close the tip of the thermometer 
in the armpit.
• Read the temperature:
• If using a digital thermometer: when the indicator sound 
(‘beep’) is heard. 
• If using a glass thermometer: after 3 min.
4.2 Infra-red tympanic (ear) measurement
• Attach a new lens filter to the tip of the thermometer each time 
it is used.
• Turn on the thermometer.
• Gently pull backwards (posteriorly) on the ear lobe to open the 
ear canal.
• Insert the probe of the thermometer into the ear canal and press 
the activation button until the beep is heard.
• Remove the thermometer from the ear and read the temperature 
on the LCD screen.
5.  Assessment of the child with fever 
at the pharmacy
Algorithm 1 (Fig. 1) presents a simple systematic approach to assist 
with identifying a child with fever who requires referral to medical 
care.
6.  Medical history and examination by 
a clinician
Fever is not a diagnosis, but a symptom of illness. A diagnosis of the 
underlying illness is essential to institute appropriate treatment.
6.1. History
Ask about:
• Fever: onset, duration, continuous or intermittent, response to 
general measures or medication.
• Associated signs and symptoms.
• Recent use of antibiotics.
• Recent vaccinations (within 48 h) and vaccination history.
• Recent travel.
• Health of other family members, exposure to sick individuals, 
crèche/school.
• Previous illnesses (including immunodeficiency and chronic 
illnesses).
• Activity level.
6.2. Examination
• Initial impression: Features of life-threatening illness, ill-looking 
child and dehydration (Table 1).
• Vital signs: Temperature, heart rate, respiratory rate, capillary refill 
time, blood pressure (if facilities available).
• Assess risk of serious illness (Algorithm 3, Fig. 3).
• A complete examination is mandatory in all children presenting 
with fever, with particular attention to possible sources of bacterial 
infection (Table 2).
Approaches to the management of fever in children aged <1 month, 1 - 
3 months and >3 months are shown in Algorithms 2 and 3 (Figs 2 and 3).
7.  General considerations for medical 
care (Evidence B)
• The degree of temperature reduction in response to antipyretic 
medication is not predictive of the presence or absence of 
bacteraemia.[6]
• Do not administer antibiotics unless there is a clear indication of 
bacteraemia.[1]
• Empirical antibiotics for possible occult bacteraemia in children >3 
months of age does not confer any significant advantage.[6] 
• If the child has signs of severe sepsis or septic shock, parenteral 
antibiotics should be administered within the first hour of 
healthcare contact.
• Provide general advice (Table  4 and Section 11) for all parents, 
especially those who are unlikely to return for follow-up (because 
of, e.g., lack of transport, parental perception that the child is not 
that ill, no telephone).
8.  Discomfort caused by pain and 
fever
• Discomfort during a febrile illness is often due to associated pain; 
e.g. myalgia, sore throat, headache.
• Antipyretics (ibuprofen and paracetamol) may be considered to 
improve comfort (with accompanying improvements in feeding 
activity and irritability), because they may also provide relief from 
pain and may reduce the risk of dehydration.[2]
9. Antipyretic medication
• Antipyretics should be used to make the child more comfortable 
and not used routinely with the sole aim of reducing the 
temperature.[1,2]
• The use of antipyretic medication and attention to the fever 
must not detract from monitoring the child’s activity and level of 
consciousness (as an indicator of worsening illness) and paying 
attention to adequate hydration.
• Both paracetamol and ibuprofen are safe and effective for short-
term use in children.[2,8-14] (Evidence A)
• The practices of combining or alternating paracetamol and ibuprofen 
have limited value and are not recommended.[15,16] (Evidence B)
• Mefenamic acid is registered for use from 6 months of age and 
may be an alternative non-steroidal anti-inflammatory (NSAID) 
to ibuprofen in children with fever. The recommended dose 
is 6.5  mg/kg of body weight, not more than three times daily 
(Evidence B). Care should be taken to avoid overdosing, which has 
been associated with adverse effects.[17,18] 
• Dose of antipyretic medication in children should be accurately 
based on body weight and should not merely be estimated 
(Tables  5  -  7). For accurate dosing, liquid medicines should be 
administered with a syringe.
• Contraindications to and precautions in the use of antipyretic 
drugs in children are listed in Table 8.
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• Aspirin should not be used in children younger than 12 years of 
age, because of the risk of Reye’s syndrome. (Evidence A)
• The use of NSAIDs has been associated with an elevated risk of 
severe skin and soft-tissue infections in patients with varicella 
zoster virus infection.[19-21] Therefore, paracetamol is recommended 
as the antipyretic of choice in children with chicken pox. 
• Medicines containing combinations of NSAID(s), paracetamol, 
codeine and/or antihistamines should not be used in children. 
(Evidence B)
10.  Vaccination and fever (Evidence B)
• Fever and a local reaction (pain, swelling, redness) are normal 
reactions to vaccination and are not harmful.
• Prophylactic administration of antipyretic drugs at the time of 
vaccination is associated with reduced antibody responses to 
vaccine antigens.[23]
• Antipyretic medication should not be administered either 
as a treatment for a local inflammatory reaction or fever, or 
prophylactically to prevent a local inflammatory reaction or fever.
All children younger than 3 months of age with a fever must be referred to a doctor
Ask the parent/carer:
About the child*
1. Is the child older than 3 months?
2. Is the child eating and drinking normally?‡
3. Is the child behaving normally?§
4. Is the child breathing normally?
About the symptoms†
5. Has the fever been present for more than 2 days?
6. Has the child had convulsions?
7. Are you very worried about the child’s health?
Yes No Yes No
Immediate referral to 
doctor or hospital
Look at the child for danger signs:†
1. Is the child lethargic or unconscious?
2. Is the child inconsolably irritable?
3. Does the child have signs of dehydration or shock? (Table 1)
Yes No
Immediate referral to 
doctor or hospital
· Dispense medicine as appropriate to make the child  
  comfortable.
· Provide parent/carer with information on when to 
  seek further medical help (Table 4).
· Provide general information (Section 11).
Fig. 1. Algorithm 1: Assessment of the child with fever at the pharmacy (Evidence B). *A ‘No’ answer to any of these questions indicates immediate referral to 
a doctor or clinic. †A ‘Yes’ answer to any of these questions/observations indicates immediate referral to a doctor or clinic. ‡Children with persistent vomiting 
should be referred. §In a child who is awake and alert, smiling, staying awake, strong crying or not crying are normal behaviours.
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• Antipyretics may be considered to make the child more comfortable 
in the event of complications associated with vaccination, such as 
cellulitis or systemic complications.
11.  Advice for parents caring for the 
child at home 
Parents require clear instructions on how to manage and monitor the 
child at home and reassurance that fever itself does not necessarily 
require treatment, but is a symptom of an illness requiring a diagnosis 
to direct specific and appropriate treatment.
11.1.  Reassure parents with anxiety about the 
child’s fever
• Fever is not an illness, but a beneficial response of the body to illness.
• Most fevers are of short duration and are not harmful.
• Children with fever are not at increased risk of seizures, 
dehydration, brain damage or death.
• Body temperature during fever normally fluctuates and the fever 
will run its course.
• The fever will return until the illness is better.
• Strict control of fever is never required.
11.2.  Advise the parent on the management of 
fever at home
• Tepid sponging is not recommended.
• Do not over-dress or under-dress the child, or wrap the child in 
heavy blankets.
• Encourage the child to drink fluids regularly (breast milk is best for 
breastfeeding children).
• To ensure that you are using the correct medication at the correct 
dose, speak to your doctor or pharmacist before administering 
medication for fever.
• Check the child during the night, but do not wake the child just to 
administer antipyretic medication.
• Seek further medical advice if the fever does not get better within 
48 h, or if the child’s condition worsens (Table 4).
11.3.  Give clear instructions on how to 
administer medication
• Correct dose.
• How to measure the dose.
• How often to administer a dose.
• Warn parents not to exceed the prescribed dose or dosing 
interval.
• Shake the bottle before pouring.
• Never measure medicine using a household teaspoon or tablespoon 
– use only the measuring device provided. Unless the medicine 
comes with a measuring device, caregivers should be provided with 
Table 1. Initial impressions when looking at the child with 
fever (Evidence A)
Potentially life-threatening features
• Compromised
• airway
• breathing
• circulation
• Decreased level of consciousness
Features characterising a toxic (ill-looking) child[6]
• pallor or cyanosis
• lethargy
• inconsolably irritable
• tachycardia (increased heart rate)
• tachypnoea (increased respiratory rate)
Symptoms of dehydration
• abnormal skin turgor
• abnormal respiratory pattern
• weak pulse
• cool extremities
• poor capillary refill (>3 s)
Table 2. Bacterial infections causing fever that must be 
excluded[1,6]
Otitis media
Urinary tract infection
Streptococcal pharyngitis
Pneumonia
Skin and soft-tissue infections (e.g. impetigo, cellulitis)
Meningitis
Bone and joint infections
Enteritis
Septicaemia/bacteraemia
Sinusitis
Table 3. Age-specific vital signs and laboratory values: Cut-off values for the definitions of SIRS, infection, sepsis, severe sepsis 
and septic shock*
Age group
Heart rate (beats/min)† Respiratory rate 
(breaths/min)†
Leukocyte count 
(×103 cells/mm3)†
Systolic blood 
pressure (mmHg)†Tachycardia Bradycardia
0 days - 1 week >180 <100 >50 >34 <65
1 week - 1 month >180 <100 >40 >19.5 or <5 <75
1 month - 1 year >180 <90 >34 >17.5 or <5 <100
2 - 5 years >140 NA >22 >15.5 or <6 <94
6 - 12 years >130 NA >18 >13.5 or <4.5 <105
13 - >18 years >110 NA >14 >11 or <4.5 <117
SIRS = systemic inflammatory response syndrome; NA = not applicable. 
* Reproduced from Goldstein et al.[7] with permission from the publisher. 
†Lower values for heart rate, leukocyte count and systolic blood pressure are for the 5th percentile and upper values for heart rate, respiratory rate and leukocyte count for the 95th percentile. 
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an appropriate syringe or measuring spoon 
whenever medicine for a child is dispensed.
• Never allow children to drink medicines 
straight from the bottle.
• Store all medicines out of the reach of 
children.
11.4.  Advise parents on the correct 
use of antipyretic medication
• Antipyretics should be used to make the 
child more comfortable and not used 
routinely with the sole aim of reducing the 
temperature.
• Antipyretics do not prevent febrile 
convulsions and should not be used 
specifically for this purpose.[1]
• Doses should be measured carefully to 
avoid over- or under-dosing.
• Antipyretic medication starts to work 
within 1 - 3 h.
• If the temperature does not come down 
after one dose, do not administer another 
dose immediately. Wait for the appropriate 
dosing interval to pass and only give 
another dose at the correct time. 
• If the child vomits immediately after 
taking a dose of medicine, another dose 
may be given.
• Antipyretic medication will not return the 
body temperature to normal unless the 
fever was low to start with.
• Sleeping children should not be awakened 
solely to administer antipyretics.
• Avoid combination products and ‘cough 
and cold medicines’, which complicate 
dosing and may increase the risk of 
overdose and side-effects.
• Antipyretic medication should not be 
administered for longer than 2 days 
without consulting a doctor.
11.5.  Provide written instructions 
about follow-up
12. Conclusion
Although fever in children is often benign and 
self-limiting, the cause of the fever can present a 
diagnostic challenge to the healthcare provider. 
However, with timeous identification, the child 
at risk of serious illness may be quickly referred 
and appropriately managed.
Parents and healthcare providers need to be 
reassured when the risk of serious illness is low, 
and the child should be managed appropriately 
at home with antipyretic medication if 
indicated to make the child more comfortable. 
Clear instructions to advise parents and 
caregivers about when to seek further care for 
their child will help to reduce the morbidity 
associated with childhood illnesses.
Conflict of interest. The development of this 
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Acute fever
Age <1 month Age 1 - 3 months
Detailed history 
and examination
Refer to paediatrician
No obvious 
source of fever
Obvious 
source of fever
Treat and 
arrange 
follow-up 
within 48 h or 
refer to 
specialist care
Refer to paediatrician
If transferring the patient:
· Stabilise the patient rst:
  Ensure respiratory and haemodynamic stability 
  Treat hypoglycaemia
· Initiate any treatment recommended telephonically by specialist before 
  transfer
Fig. 2. Algorithm 2: Investigation of acute fever in children aged 0 - 3 months.
Table 4. Indications to seek further medical assistance when caring for the child at 
home (Evidence A)
1. Signs of dehydration
• sunken fontanelle
• dry mouth
• absence of tears
• sunken eyes
• poor overall appearance
• abnormal breathing
2. Development of a rash
3. The child has a seizure (fit)
4. The child cries inconsolably (cannot be calmed down), or cries when you touch him/her
5. The child stops drinking or eating
6. The child’s urine becomes dark in colour
7. The child’s condition gets worse
8. Fever lasts for longer than 2 days
9. You are concerned for any other reason
Table 5. Dose of antipyretic medication for children older than 3 months of age[2,22](Evidence B)
Oral dose (mg/kg) Dose frequency Maximum daily dose (mg/kg)*
Ibuprofen 10 every 6 h, as necessary 40
Paracetamol 15 (up to 1 g) every 4 - 6 h, as necessary 90 (4 g in total)
*Do not exceed this dose within a 24-h period.
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Detailed history and examination
Obvious source of fever No obvious source of fever
Treat and arrange follow-up 
within 48 hours
Assess for symptoms and signs to 
predict risk of serious illness*
High risk
· Unable to rouse or if roused does not stay awake
· Weak, high-pitched or continuous cry
· Pale/mottled/blue/ashen
· Reduced skin turgor
· Moderate or severe chest indrawing
· Respiratory rate >60 breaths/min
· Grunting
· Bulging fontanelle
· Appearing ill to a healthcare professional (Table 1)
· Age 3 - 6 months and temperature ≥39°C
· Non-blanching rash
· Neck stiness, focal neurological signs
· Focal seizures
· Bile-stained vomiting
Intermediate risk
· Wakes up only with prolonged stimulation
· Decreased activity
· Poor feeding in infants
· Not responding normally to social cues, no smile
· Dry mucous membranes
· Reduced urine output
· Pallor reported by parent or carer
· Nasal flaring
· Tachypnoea - Respiratory rate:
 Age 3 - 12 months: >50 breaths/min
 Age 12 - 59 months: >40 breaths/min
· A new lump larger than 2 cm
· Non weight bearing, not using an extremity
· Other signs of dehydration
Low risk
· Strong cry or not crying
· Content/smiles
· Stays awake
· Normal colour of skin, lips and 
  tongue
· Normal skin and eyes
· Moist mucous membranes
· Normal response to social 
  cues
Urgent referral to paediatric specialist or 
hospital
· Stabilise the patient rst:
  Ensure respiratory and haemodynamic stability
  Treat hypoglycaemia
· If time from referral to hospital is >1 hour:
  Give rst dose of an appropriate intramuscular 
  antibiotic
· Reassurance and home 
  management
· Advise follow-up if symptoms 
  do not resolve within 24 - 48  
  hours
· General advice on when to 
  seek further medical help 
  (Table 4)
Abnormal physiology (Table 3)
Yes No
Refer, or telephonic consultation with specialist
Special investigations as indicated
Diagnosis
No Yes
· Treat underlying illness
· Consider antipyretic medication to improve 
  comfort if no contraindications
· Arrange follow-up within 48 hours
Fig. 3. Algorithm 3: Investigation of acute fever in children >3 months of age. *Risk stratification adapted from National Institute for Health and Clinical 
Excellence (NICE).[1] 
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Table 6. Dose by body weight for oral liquid:  
Ibuprofen 100 mg/5 ml
Body weight (kg) Medicine measure (ml)* 
6 3
9 4.5
12 6
15 7.5
18 9
21 10.5
24 12
27 13.5
30 15
33 15
36 15
39 15
*Administer not more frequently than every 6 h.
Table 7. Dose by body weight for oral liquid: 
Paracetamol 120 mg/5 ml
Body weight (kg) Medicine measure (ml)
6 3.7
9 5.6
12 7.5
15 9.4
18 11.2
21 13.1
24 15
*Administer not more frequently than every 4 - 6 h.
Table 8. Contraindications and precautions to the use of antipyretic drugs in children[22] (Evidence C)
NSAIDs Paracetamol
Contraindications Hypersensitivity, active peptic ulceration or upper GI bleeding, severe 
renal failure, hepatic or cardiac failure
Precautions Asthma, cardiac disease, dehydration, concomitant use of drugs that 
increase risk of bleeding, previous peptic ulceration, coagulation defects, 
allergic disorders, renal or hepatic impairment
Hepatic impairment, renal 
impairment, overdose
NSAIDs = non-steroidal anti-inflammatory drugs; GI = gastrointestinal.
